ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through clinical trials.…
Bristol-Myers Squibb released better-than-expected second-quarter financial results before the markets opened Thursday.
Chris Lange The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short interest decreased.
How much are big pharmaceutical companies really spending to get their drugs out there in the public eye?
The June 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
The May 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest is down.
Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical companies in its coverage.
ThinkstockThe American Society of Clinical Oncology’s (ASCO) annual meeting is coming to a close. Companies and cancer drug developers across the health care sector flock to this conference to share results from…
The short interest data has been released for the May 15 settlement date and for the selected pharmaceutical stocks, short interest is mixed.
The April 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
In a new report, the RBC team focused on the companies that are making the most progress with treatments for patients with breast cancer.
Credit Suisse has released a report that detailed its top picks for pharmaceutical stocks for the rest of 2015.
ThinkstockThe trend towards generic drugs is nothing new. It does not matter if a drug has billions of dollars in annual sales or not, when they go off patent generics can enter…
Tuesday's top analyst upgrades, downgrades and initiations include GE, IBM, Bristol-Myers Squibb, Encana, Halliburton, Rio Tinto and WhiteWave Foods.
In a new report, Cowen analysts have sights set on three major pharmaceutical stocks that they expect to have rising first-quarter earnings.
